Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 836 results for "eli lilly"

Eli Lilly and Now Covered by Berenberg Bank (LLY)
WKRB News

Eli Lilly and Now Covered by Berenberg Bank (LLY)

Berenberg Bank started coverage on shares of Eli Lilly and (NYSE:LLY) in a research report report published onThursday, Market Beat.com reports. The firm issued a buy rating and a $100.00 price target on the stock. Eli Lilly and ( NYSE:LLY ) ... WKRB News, 6 hours ago
[x]  

165 images for eli lilly

SleekMoney, 1 day ago
American Banking News, 4 days ago
ClinicSpace, 3 days ago
Yahoo! Finance, 3 days ago
InvestorPlace.com, 1 week ago
Octafinance, 4 days ago
Pharma Letter, 3 days ago
Jutia Group, 3 days ago
Octafinance, 4 days ago
Endocrinology Advisor, 1 week ago
TheStreet.com

Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock?

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- A new Eli Lilly and Company ( LLY - Get Report ) drug is causing controversy , and it hasn't even been approvedyet. The drug will help treat smokers who have lung cancer. The ...
 TheStreet.com3 days ago New Drug Development Study Findings Have Been Reported by Investigators at Eli Lilly (An analysis of the attrition of drug candidates from four major...  Pharmacy Choice1 month ago
Bidness Etc

Eli Lilly Leads US Large Pharma In 2015; Johnson & Johnson Ranks Lowest

Over the past week, stock markets worldwide suffered from the spill-over effect of an ongoing crisis in China's mainland stock markets. International markets, particularly emerging ones, declined on concerns that a decelerating Chinese economy, ...
 Bidness Etc5 days ago
TheStreet.com

Cramer -- Stick With Eli Lilly, Take Mohawk Industries Over Lumber Liquidators

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- The S&P 500 is down 1.2% Thursday but not all stocks are having a bad day. Shares of Eli Lilly ( LLY - Get Report ) are up nearly 5% following positive data for its Jardiance drug. The ...
 TheStreet.com1 week ago
Benzinga.com

Analyst's Key Takeaways From Eli Lilly, Bristol-Myer Squibb's Latest Conference Calls

In separate reports published Thursday, Evercore-ISI's Biotechnology analyst Mark Schoenebaum dissected Eli Lilly and Co (NYSE: LLY) and Bristol-Myers Squibb Co (NYSE: BMY)'s conference call following the release of their quarterly results. Here ...
 Benzinga.com1 month ago Eli Lilly CEO: Obamacare out-of-pocket costs high  Yahoo! Finance1 month ago Eli Lilly CEO Explains The Reasons Behind The $0.16 EPS Beat  Fat Pitch Financials1 month ago Eli Lilly, Biogen shares mixed on Alzheimer's studies  Yahoo! UK and Ireland1 month ago
[x]  

Eli Lilly (LLY) Crosses Pivot Point Resistance at $85.02

Shares of Eli Lilly (NYSE:LLY) opened today above their pivot of $84.50 and have already reached the first level of resistance at $85.02. Investors may be interested in a cross of the next upside pivot targets of $85.49
 Individual.com1 month ago Eli Lilly (LLY) Breaks Through Support at $84.54  Individual.com1 month ago Watch for Shares of Eli Lilly (LLY) to Approach Resistance at $85.31  Individual.com1 month ago Eli Lilly (LLY) Breaks Through Resistance at $87.66  Individual.com1 month ago
EHealth Magazine

Eli Lilly to Introduce New Diabetes Medication in India

Representational Image Eli Lilly, a US-based pharma company is all set to launch a new medication to enhance its diabetes treatment portfolio by the end of the year in India. The company has received regulatory approval for the upcoming ...
 EHealth Magazine2 weeks ago Eli Lilly plans to launch new medication for diabetes in India  Business Standard2 weeks ago Pharma Company, Eli Lilly To Launch New Diabetes Drug In India  MedIndia2 weeks ago Pharmaceutical Company, Eli Lilly, Plans To Launch New Diabetes Drug In India  Med India2 weeks ago

Eli Lilly (LLY) Trading Near $85.60 Resistance Level

MarketIntelligenceCenter.comaEUR(TM)s patented option-trade picking algorithm found two trade ideas on Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) today after it traded between between $84.38 and $85.25 before closing ...
 Individual.com4 weeks ago Eli Lilly (LLY) Trading Near $82.76 Support Level  PredictWallStreet1 month ago Eli Lilly (LLY) Showing Bullish Technicals With Resistance At $87.08  PredictWallStreet1 month ago Eli Lilly (LLY) Showing Support Near $83.98  Individual.com1 month ago
ClinicSpace

Eli Lilly to continue evacetrapib phase 3 trial

Eli Lilly and Company, a global healthcare leader, has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the phase 3 trial of the investigational medicine evacetrapib, based on data from an interim futility ...
 PharmaBiz1 month ago Healthcare Stocks Buzz- Eli Lilly (LLY), Array Biopharma (ARRY), Opko Health (OPK), Keryx Biopharmaceuticals (KERX)  Techsonian1 month ago Eli Lilly To Continue Phase 3 Trial Of Evacetrapib - Quick Facts  RTTNews.com1 month ago Eli Lilly (LLY) Provides Update On Evacetrapib Phase 3 Trial 7/27/2015  ClinicSpace1 month ago

Potential Eli Lilly (LLY) Trade Has 3.02% Downside Protection

A covered call identified by MarketIntelligececenter.com's patented algorithms on Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) could yield about 3.67% (17.40% annualized, for comparison purposes only) in 77 days. Pair a ...
 Individual.com1 month ago Potential Eli Lilly (LLY) Trade Targets 3.65% Return  Individual.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less